✦ LIBER ✦
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males
✍ Scribed by Patrick G. Clay; Maqual R. Graham; Cameron C. Lindsey; Kenneth C. Lamp; Collin Freeman; Alan Glaros
- Book ID
- 119187787
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 767 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1543-5946
No coin nor oath required. For personal study only.